The trajectory of Viagra, initially marketed by copyright, presents a complex case study for backers considering the pharmaceutical arena . Despite its early success and generation of billions in sales, the exclusivity lapse has opened the way for competing medications, significantly diminishing earnings prospects . This transition raises doubts ab